Sample Articles
- Hospira sets ball rolling on push towards globalisation
Expanding its generic injectables portfolio outside the US and pushing into emerging markets are among the key strategies of Hospira’s new head, Mike Ball.
Read More... - Italy is turning the corner after reference-price cuts
Italian industry’s refusal to bow to reference-price reductions has provided the spur for initiatives to raise volumes.
Read More... - Hikma sees bright side of turmoil in MENA region
The current social and political unrest in the Middle East and North Africa will bring beneficial reforms, Jordan’s Hikma believes.
Read More... - France continues to grow but recent launches falter
Sales of reference brands listed in France’s répertoire of generics are growing faster than those of their equivalents, as David Wallace reports.
Read More... - Watson is authorised to expand rapidly in 2011
Watson believes that its 2011 generics growth will come primarily from its US authorised-generic launches.
Read More... - Actavis aims to become global player in diabetes
Actavis will build an international diabetes franchise around analogue insulins, the firms chief executive Claudio Albrecht told Aidan Fry.
Read More...
our latest front page |
 |
 |
